Zenas Biopharma earnings were -$425.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ZBIO earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$81.0M, down 66.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ZBIO reported annual earnings of -$377.7M, with 140.6% growth. The next ZBIO earnings date is Aug 11, 2026.
What were Zenas Biopharma's earnings last quarter?
Zenas Biopharma (NASDAQ: ZBIO) reported Q1 2026 earnings per share (EPS) of -$1.46, up 82.5% year over year. Total ZBIO earnings for the quarter were -$80.99 million. In the same quarter last year, Zenas Biopharma's earnings per share (EPS) was -$0.80.
The next ZBIO earnings call is Invalid Date. Add ZBIO to your watchlist to be reminded of Zenas Biopharma's next earnings date.
Is Zenas Biopharma profitable or losing money?
As of the last Zenas Biopharma earnings report, Zenas Biopharma is currently losing money. Zenas Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$425.15 million, a 161.21% increase year over year.
What was ZBIO's earnings growth in the past year?
As of Zenas Biopharma's earnings date in Q3 2026, Zenas Biopharma's earnings has grown year over year. ZBIO earnings in the past year totalled -$425.15 million.
What are Zenas Biopharma's earnings expectations?
The current EPS estimate for Zenas Biopharma's earnings report in Invalid Date is -$0.89.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.